1984
DOI: 10.1093/clinchem/30.6.860
|View full text |Cite
|
Sign up to set email alerts
|

Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity.

Abstract: Using the chromogenic substrate S-2222, we have optimized and automated an amidolytic assay for heparin. The assay is based on the detection of anti-Xa activity generated by heparin in plasma. The method is reproducible (intra- and interassay CVs of 2.4 and 3.3%, respectively) and reliable in antithrombin III-deficient plasma. Results of this assay, obtained for plasma samples from patients and volunteers treated with heparin, correlate well (r = 0.899) with those of the test for activated partial thromboplast… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

1985
1985
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(8 citation statements)
references
References 10 publications
0
8
0
Order By: Relevance
“…Thrombin‐AT complexes (TATc; Dade Behring, Marburg, Germany) and D‐dimer (Diagnostica Stago, Roche, Almere, the Netherlands) were measured by ELISA. AT [16] and plasminogen activator (PA) activity [17] were measured by automated amidolytic techniques. Tissue‐type plasminogen activator (t‐PA) antigen was measured with an ELISA.…”
Section: Methodsmentioning
confidence: 99%
“…Thrombin‐AT complexes (TATc; Dade Behring, Marburg, Germany) and D‐dimer (Diagnostica Stago, Roche, Almere, the Netherlands) were measured by ELISA. AT [16] and plasminogen activator (PA) activity [17] were measured by automated amidolytic techniques. Tissue‐type plasminogen activator (t‐PA) antigen was measured with an ELISA.…”
Section: Methodsmentioning
confidence: 99%
“…It has been over 90 years since the discovery of heparin as an effective anticoagulant. The mechanism of anticoagulant is to activate antithrombin III (ATIII) by the allosteric effect through the speci c combination of polysaccharide sequence and ATIII [12][13][14] . The activated ATIII can inhibit a variety of coagulation factors including Xa, IIa, IXa, XIa, XIIa etc., to exert the anticoagulant activity.…”
Section: Discussionmentioning
confidence: 99%
“…Determination of the activated partial thromboplastin time (aPTT) was performed according to unfractionated procedures in citrated plasma. The chromogenic anti-factor Xa activity assay was performed using an EPOS 5060 analyzer, as described previously (20), and calibrated against a Fraxiparin standard. The plasma anti-factor Ila assay was performed as described elsewhere (21 ).…”
Section: Blood Sampling and Assaysmentioning
confidence: 99%